Synucleinopathies, including Parkinson’s disease, are characterized by α-synuclein aggregation and progressive neurodegeneration, yet the early molecular events linking SNCA gene dosage to disrupted proteostasis remain poorly understood. Here, we used human midbrain organoids carrying an SNCA tri...
ORGANISM(S): Homo sapiens (Human)
